• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Sanofi's Sarclisa cuts death risk in mutiple myeloma pharmatimes
    May 13, 2020
    Sanofi's monoclonal antibody Sarclisa (isatuximab) has hit targets in a late-stage trial, reducing the risk of disease progression or death in patients with relapsed multiple myeloma.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service